L-AmB
(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2S,3R,4R,5R,6S)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid
Molecular Identity
L-AmB
(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2S,3R,4R,5R,6S)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid
PubChem CID: 44405442
2D Structure
Properties
C47H73NO17
Molecular Formula
924.10
Molecular Weight
g/mol
923.4878
Exact Mass
Da
0
XLogP
Drug-like (Lipinski: < 5)
320
TPSA
May have limited oral absorption
12
H-Bond Donors
18
H-Bond Acceptors
1670
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(7)
L-AmBLiposomal Amphotericin BRefChem:799325Amphotericin B-Lipid ComplexLipid Complex, Amphotericin BAmphotericin B LiposomalSCHEMBL18488043
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to L-AmB
Loading drug network...